Local effect of intranasal beclomethasone dipropionate aerosol in perennial rhinitis.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001507:Beclomethasone / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004844:Epistaxis / Q000139:chemically induced; D005260:Female; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009297:Nasal Mucosa / Q000378:metabolism; D010919:Placebos; D012138:Respiratory Therapy; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012912:Sneezing; D013997:Time Factors
D000336:Aerosols; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D010919:Placebos; D001507:Beclomethasone